Skip to playerSkip to main content
  • 7 weeks ago
Research conducted at the Kennedy Institute of Oxford indicates that susceptibility to rheumatoid arthritis may be determined prior to birth. By examining finger joints typically impacted by the condition versus those that remain unaffected, the study revealed that the at-risk joints exhibited a greater amount of synovial tissue and a higher concentration of specialized fibroblasts during fetal development. These cells also showed different responses to inflammatory signals. Utilizing advanced single-cell sequencing techniques and high-resolution three-dimensional imaging, the researchers provided an unprecedented view of developing human joints, suggesting that anatomical differences established in utero could influence future inflammation patterns. The results, detailed in Nature Immunology, may pave the way for new insights into the understanding and treatment of the condition.
Disclosure:
This video contains stock footage and content created or enhanced using AI-assisted tools.

ai-generated
Transcript
00:00Why does rheumatoid arthritis attack some joints and completely spare others?
00:04Scientists at Oxford's Kennedy Institute think they finally have an answer,
00:08and it starts before you're even born.
00:11Researchers compared finger joints that are commonly hit by the disease
00:14with joints nearby that are almost always spared.
00:17They found that the vulnerable joints already had more synovial tissue
00:21and a bigger population of specialized connective tissue cells
00:25while still developing in the womb.
00:26Those cells also responded differently when exposed to inflammatory signals
00:31using cutting-edge single-cell sequencing and high-resolution 3D imaging.
00:36The team built one of the most detailed maps ever made of developing human joints.
00:41The conclusion, the architecture of a joint laid down before birth,
00:45may help decide years or even decades later whether arthritis takes hold there.
00:50The findings, published in Nature Immunology, could open entirely new paths for understanding
00:55and eventually treating one of the most common autoimmune diseases in the world.
01:01Disclosure, this video contains stock footage and content created or enhanced
01:04using AI-assisted tools.

Recommended